This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Innovations of Vladimir Ivanovich Bouroumov
Introduction
Vladimir Ivanovich Bouroumov is a notable inventor based in Novosibirsk, Russia. He has made significant contributions to the field of pharmacology, particularly in the development of antiviral products. His innovative work focuses on creating effective treatments for viral infections, including HIV.
Latest Patents
Bouroumov holds a patent for an antiviral water-soluble product with an anti-HIV effect, which is based on a compound of ionic silver and methylene blue. This new substance is produced in the form of a water-soluble powder, which can be utilized for preparing finished dosage forms aimed at treating viral infections, especially HIV. The product, known as Argothiazin-A™, has the potential to radically suppress infectious agents without causing mutations or resistance in viruses. The chemical formula for this innovative product is CHAgNOS.
Career Highlights
Throughout his career, Bouroumov has focused on developing novel pharmacological solutions to combat viral infections. His dedication to research and innovation has led to the creation of a product that could significantly impact the treatment of HIV. His work exemplifies the importance of scientific advancement in addressing global health challenges.
Collaborations
Bouroumov has collaborated with notable colleagues, including Harvey E Svetlik and Vasily Vasilievich Tretiakov. These partnerships have contributed to the development and refinement of his innovative antiviral products.
Conclusion
Vladimir Ivanovich Bouroumov's contributions to antiviral pharmacology highlight the potential for innovation in treating viral infections. His work, particularly in developing Argothiazin-A™, represents a significant advancement in the fight against HIV.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile